Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TRONDHEIM ENDOKRINOLOGISENTER AS
AS
Active
Org 914742374
Kjøpmannsgata 31, 7011 Trondheim
Medical specialists activities · NACE 8622
Est. 2015
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 3,8M
+26% vs 2022
EBITDA margin
33.1%
+63% vs 2022
Equity ratio
5.2%
Financial strength
Net profit 2023
NOK 999K
+77% vs 2022
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2019
1M
0%
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
Key figures
Annual report 2023
Revenue
NOK 3,8M
+26%
EBITDA
NOK 1,3M
+63%
Net profit
NOK 999K
+77%
Total assets
NOK 1,9M
+2%
Equity
NOK 98K
-75%
Employees
3
—
Company information
Legal name
TRONDHEIM ENDOKRINOLOGISENTER AS
Org number
914742374
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
19. januar 2015
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Spesialisert legevirksomhet i indremedisin og tilknyttede sykdommer.
Contact
Address
Kjøpmannsgata 31, 7011 Trondheim
Phone
+4773834358
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Trondheim
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
5M
3M
2019
3M
2020
3M
2021
3M
2022
4M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2019
1M
2020
1M
2021
1M
2022
1M
2023
Income statement
NOK thousands
Item
2019
2020
2021
2022
2023
Revenue
2 999
3 056
2 996
3 051
3 846
Staff expenses
−1 305
−1 270
−1 382
−1 285
−1 438
EBITDA
751
783
698
782
1 273
Depreciation & amort.
−24
−49
−52
−53
−11
EBIT
726
735
646
729
1 262
Net financials
21
−14
10
13
20
Profit before tax
747
749
656
742
1 282
Tax
168
167
147
178
283
Net profit
579
582
509
564
999
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
2023
Total assets
3 251
2 220
1 560
1 844
1 883
Equity
1 144
1 127
835
399
98
Long-term debt
0
0
0
0
0
Short-term debt
2 106
1 094
725
1 445
1 785
Total debt
2 106
1 094
725
1 445
1 785
Financial ratios
5-year trend
EBITDA margin
33.1%
This company
15.8%
Market median
+109% vs market
2019
2023
Equity ratio
5.2%
This company
38.2%
Market median
-86% vs market
2019
2023
Return on equity
1019.9%
This company
18.4%
Market median
+5443% vs market
2019
2023
Net profit margin
26.0%
This company
8.1%
Market median
+221% vs market
2019
2023
Asset turnover
2.04×
This company
1.12×
Market median
+82% vs market
2019
2023
Debt / equity
18.22×
This company
0.62×
Market median
-2839% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KA
Katarzyna Anna Baranowska
Deputy Member
Deputy Member
2015
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
TE
Tore Eklo
Board of Directors
2023
MM
Marek Michal Baranowski
Chairman
2015
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TRONDHEIM ENDOKRINOLOGISENTER AS also hold positions in
0
other companies.
Person
Role here
Other companies
Katarzyna Anna Baranowska
Deputy Member
0 companies
Tore Eklo
Board of Directors
0 companies
Marek Michal Baranowski
Chairman
0 companies